MedinCell has secured a €40 million ($42 million) loan from the European Investment Bank (EIB), positioning the Teva-partnered pharma company to develop therapies based on its long-acting injectable drug delivery technology.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,